These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1245091)

  • 1. Disposition kinetics of quinidine.
    Ueda CT; Hirschfeld DS; Scheinman MM; Rowland M; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Jan; 19(1):30-6. PubMed ID: 1245091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition kinetics of dihydroquinidine following quinidine administration.
    Ueda CT; Williamson BJ; Dzindzio BS
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):215-25. PubMed ID: 940955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of quinidine and three of its metabolites in man.
    Rakhit A; Holford NH; Guentert TW; Maloney K; Riegelman S
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):1-21. PubMed ID: 6747817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-time effects of quinidine disposition kinetics in rhesus monkeys.
    Ueda CT; Ballard B; Rowland M
    J Pharmacol Exp Ther; 1977 Mar; 200(3):459-68. PubMed ID: 403278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition kinetics of two oral forms of quinidine.
    Mahon WA; Mayersohn M; Inaba T
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):566-75. PubMed ID: 1277713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies of quinidine in patients with arrhythmias.
    Conrad KA; Molk BL; Chidsey CA
    Circulation; 1977 Jan; 55(1):1-7. PubMed ID: 830196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion kinetics of intact quinidine and 3-OH-quinidine after oral administration of a single oral dose of quinidine gluconate in the fasting and non-fasting state.
    St-Onge JM; Sirois G; Gagnon MA
    Eur J Drug Metab Pharmacokinet; 1983; 8(4):363-72. PubMed ID: 6673973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute quinidine bioavailability.
    Ueda CT; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Sep; 20(3):260-5. PubMed ID: 954347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative disposition kinetics of two diastereomeric pairs of cinchona alkaloids in the dog.
    Abraham I; Ueda CT
    J Pharm Sci; 1984 Apr; 73(4):452-6. PubMed ID: 6726627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies.
    Guentert TW; Holford NH; Coates PE; Upton RA; Riegelman S
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):315-30. PubMed ID: 512840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of quinidine in the rabbit.
    Guentert TW; Huang JD; Oie S
    J Pharm Sci; 1982 Jul; 71(7):812-5. PubMed ID: 7120069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of caffeine on the oral absorption and disposition of quinidine.
    Zeller FP; Ueda CT; Wulf BG; Meyers DG
    Clin Pharm; 1984; 3(1):72-5. PubMed ID: 6697677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and dynamics of quinidine-N-oxide in healthy subjects.
    Ha HR; Vozeh S; Uematsu T; Guentert TW; Follath F
    Clin Pharmacol Ther; 1987 Sep; 42(3):341-5. PubMed ID: 3621790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of quinidine metabolism and plasma protein binding by phenobarbital in dogs.
    Rakhit A; Holford NH; Effeney DJ; Riegelman S
    J Pharmacokinet Biopharm; 1984 Oct; 12(5):495-515. PubMed ID: 6520745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition kinetics of ethambutol in man.
    Lee CS; Brater DC; Gambertoglio JG; Benet LZ
    J Pharmacokinet Biopharm; 1980 Aug; 8(4):335-46. PubMed ID: 7431225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of dihydroquinidine in congestive heart failure patients after intravenous quinidine administration.
    Ueda CT; Dzindzio BS
    Eur J Clin Pharmacol; 1979 Sep; 16(2):101-5. PubMed ID: 499305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction.
    Schenck-Gustafsson K; Dahlqvist R
    Br J Clin Pharmacol; 1981 Feb; 11(2):181-6. PubMed ID: 7213521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and electrocardiographic changes after oral 3-OH-quinidine in healthy subjects.
    Vozeh S; Uematsu T; Guentert TW; Ha HR; Follath F
    Clin Pharmacol Ther; 1985 May; 37(5):575-81. PubMed ID: 3987181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bioavailability and kinetics of dihydroquinidine in patients with heart disease.
    Regazzi Bonora M; Salerno JA; Rondanelli R; Cristiani D; Chimienti M
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):212-8. PubMed ID: 7095920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.